Company intelligence / Profile preview

VIDA Diagnostics

Coralville, Iowa, United Statesvidalung.ai ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

VIDA Diagnostics provides AI-powered imaging analysis services and software to accelerate drug development in respiratory, cardiovascular, and oncology indications. Their platform is used in over 30 active trials globally with more than 500,000 scans analyzed. Their technology is validated by regulatory clearances across major markets[3][5][8].

Therapeutic areas: PulmonologyCardiovascularOncologyInfectious Diseases
Modalities: Device (Imaging software)Artificial intelligence-powered digital biomarkers
Industry: Contract Research Organization

Partnerships

Olympus Medical (commercialization partnership)UnityPoint Health (clinical data access partnership)OSF Ventures / OSF HealthCare (strategic investment & clinical collaboration)

Beyond the preview

Go deeper on VIDA Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIDA Diagnostics.

Explore the full profile